{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T09:10:06Z","timestamp":1794301806222,"version":"4.9.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T00:00:00Z","timestamp":1755993600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100016224","name":"University Medical Centre Maribor","doi-asserted-by":"publisher","award":["IRP-2023\/01-03"],"award-info":[{"award-number":["IRP-2023\/01-03"]}],"id":[{"id":"10.13039\/501100016224","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcardioanesthesia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1053\/j.jvca.2025.08.044","type":"journal-article","created":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T22:22:53Z","timestamp":1755987773000},"page":"3359-3367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Real-world Experience of Angiotensin II and Renin Usage in Patients With Distributive Shock:A Single-center Descriptive Study"],"prefix":"10.1053","volume":"39","author":[{"given":"Andreja","family":"M\u00f6ller Petrun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Gorenjak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franc","family":"Sven\u0161ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nives","family":"Matkovi\u0107 Lonzari\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alenka","family":"Strdin Ko\u0161ir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Cvikl Knehtl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgenija","family":"Hom\u0161ak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u017diga","family":"Kalamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8594-5980","authenticated-orcid":false,"given":"Giovanni","family":"Landoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrej","family":"Markota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2025.08.044_bib0001","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1053\/j.jvca.2024.12.022","article-title":"The efficacy and safety of angiotensin II for treatment of vasoplegia in critically ill patients: A systematic review","volume":"39","author":"Kotani","year":"2025","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2025.08.044_bib0002","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.chest.2020.08.2074","article-title":"Angiotensin II infusion for shock: A multicenter study of postmarketing use","volume":"159","author":"Wieruszewski","year":"2021","journal-title":"Chest"},{"key":"10.1053\/j.jvca.2025.08.044_bib0003","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.bja.2023.06.056","article-title":"Renin-angiotensin-aldosterone system dynamics after targeted blood pressure control using angiotensin II or norepinephrine in cardiac surgery: Mechanistic randomised controlled trial","volume":"131","author":"Coulson","year":"2023","journal-title":"Br J Anaesth"},{"key":"10.1053\/j.jvca.2025.08.044_bib0004","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/SHK.0000000000002109","article-title":"A pilot study of angiotensin II as primary vasopressor in critically ill adults with vasodilatory hypotension: The ARAMIS study","volume":"59","author":"See","year":"2023","journal-title":"Shock"},{"key":"10.1053\/j.jvca.2025.08.044_bib0005","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1213\/ANE.0000000000005953","article-title":"The association between angiotensin II and renin kinetics in patients after cardiac surgery","volume":"134","author":"Meersch","year":"2022","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2025.08.044_bib0006","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1213\/ANE.0000000000006839","article-title":"A pilot study of renin-guided angiotensin-II infusion to reduce kidney stress after cardiac surgery","volume":"139","author":"Sadjadi","year":"2024","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2025.08.044_bib0007","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00134-023-07290-7","article-title":"Angiotensin II","volume":"50","author":"Bellomo","year":"2024","journal-title":"Intensive Care Med"},{"key":"10.1053\/j.jvca.2025.08.044_bib0008","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s44158-024-00150-w","article-title":"Angiotensin II therapy in refractory septic shock: Which patient can benefit most? A narrative review","volume":"4","author":"Coloretti","year":"2024","journal-title":"J Anesth Analg Crit Care"},{"key":"10.1053\/j.jvca.2025.08.044_bib0009","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJMoa1704154","article-title":"Angiotensin II for the treatment of vasodilatory shock","volume":"377","author":"Khanna","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2025.08.044_bib0010","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1164\/rccm.201911-2172OC","article-title":"Renin and survival in patients given angiotensin II for catecholamine-resistant vasodilatory shock. A clinical trial","volume":"202","author":"Bellomo","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/j.jvca.2025.08.044_bib0011","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/01.ccm.0000528062.45598.be","article-title":"Effect of disease severity on survival in patients receiving angiotensin II for vasodilatory shock","volume":"46","author":"Szerlip","year":"2018","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2025.08.044_bib0012","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/CCM.0000000000003092","article-title":"Outcomes in patients with vasodilatory shock and renal replacement therapy treated with intravenous angiotensin II","volume":"46","author":"Tumlin","year":"2018","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2025.08.044_bib0013","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13054-023-04446-1","article-title":"Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: An exploratory post-hoc analysis of the ATHOS-3 clinical trial","volume":"27","author":"Wieruszewski","year":"2023","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2025.08.044_bib0014","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/0885066620972943","article-title":"A multicenter observational cohort study of angiotensin II in shock","volume":"37","author":"Smith","year":"2022","journal-title":"J Intensive Care Med"},{"key":"10.1053\/j.jvca.2025.08.044_bib0015","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ccc.2018.11.002","article-title":"Classic and nonclassic renin-angiotensin systems in the critically ill","volume":"35","author":"Bitker","year":"2019","journal-title":"Crit Care Clin"},{"key":"10.1053\/j.jvca.2025.08.044_bib0016","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/CCM.0000000000003582","article-title":"Tissue perfusion and prognosis in the critically ill-Is renin the new lactate?","volume":"47","author":"Khanna","year":"2019","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2025.08.044_bib0017","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1213\/ANE.0000000000006682","article-title":"Renin as a prognostic marker in intensive care and perioperative settings: A scoping review","volume":"138","author":"Kotani","year":"2024","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2025.08.044_bib0018","doi-asserted-by":"crossref","first-page":"9133","DOI":"10.3390\/ijms23169133","article-title":"Renin as a marker of tissue perfusion, septic shock and mortality in septic patients: A prospective observational study","volume":"23","author":"Le\u015bnik","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1053\/j.jvca.2025.08.044_bib0019","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4266\/kjccm.2017.00094","article-title":"Implications of plasma renin activity and plasma aldosterone concentration in critically ill patients with septic shock","volume":"32","author":"Chung","year":"2017","journal-title":"Korean J Crit Care Med"},{"key":"10.1053\/j.jvca.2025.08.044_bib0020","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/CCM.0000000000006095","article-title":"Association of active renin content with mortality in critically ill patients: A post hoc analysis of the Vitamin C, Thiamine, and Steroids in Sepsis (VICTAS) trial","volume":"52","author":"Busse","year":"2024","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2025.08.044_bib0021","doi-asserted-by":"crossref","first-page":"R328","DOI":"10.1186\/cc2902","article-title":"Erythropoietin and renin as biological markers in critically ill patients","volume":"8","author":"Tamion","year":"2004","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2025.08.044_bib0022","first-page":"1","article-title":"Fitting linear mixed-effects models using lme4","volume":"671","author":"Bates","year":"2015","journal-title":"J Stat Softw"},{"key":"10.1053\/j.jvca.2025.08.044_bib0023","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13054-023-04322-y","article-title":"An updated \"norepinephrine equivalent\" score in intensive care as a marker of shock severity","volume":"27","author":"Kotani","year":"2023","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2025.08.044_bib0024","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jpainsymman.2016.12.333","article-title":"Intensity of vasopressor therapy for septic shock and the risk of in-hospital death","volume":"53","author":"Brand","year":"2017","journal-title":"J Pain Symptom Manage"},{"key":"10.1053\/j.jvca.2025.08.044_bib0025","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4037\/ajcc2016667","article-title":"Norepinephrine dosing in obese and nonobese patients with septic shock","volume":"25","author":"Radosevich","year":"2016","journal-title":"Am J Crit Care"},{"key":"10.1053\/j.jvca.2025.08.044_bib0026","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1097\/00003246-200110000-00002","article-title":"Infusion of methylene blue in human septic shock: A pilot, randomized, controlled study","volume":"29","author":"Kirov","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2025.08.044_bib0027","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.chest.2022.09.021","article-title":"High-dose IV hydroxocobalamin (vitamin B12) in septic shock: A double-blind, allocation-concealed, placebo-controlled single-center pilot randomized controlled trial (The Intravenous Hydroxocobalamin in Septic Shock Trial)","volume":"163","author":"Patel","year":"2023","journal-title":"Chest"},{"key":"10.1053\/j.jvca.2025.08.044_bib0028","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00134-018-5197-6","article-title":"Low-dose corticosteroids for adult patients with septic shock: A systematic review with meta-analysis and trial sequential analysis","volume":"44","author":"Ryg\u00e5rd","year":"2018","journal-title":"Intensive Care Med"},{"key":"10.1053\/j.jvca.2025.08.044_bib0029","first-page":"e0634","article-title":"Association of arterial pH with hemodynamic response to vasopressin in patients with septic shock: An observational cohort study","volume":"4","author":"Bauer","year":"2022","journal-title":"Crit Care Explor"},{"key":"10.1053\/j.jvca.2025.08.044_bib0030","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13054-024-04910-6","article-title":"ACE inhibitors and angiotensin receptor blockers differentially alter the response to angiotensin II treatment in vasodilatory shock","volume":"28","author":"Leisman","year":"2024","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2025.08.044_bib0031","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.jvca.2020.08.001","article-title":"Treatment with angiotensin II is associated with rapid blood pressure response and vasopressor sparing in patients with vasoplegia after cardiac surgery: A post-hoc analysis of Angiotensin II for the Treatment of High-Output Shock (ATHOS-3) study","volume":"35","author":"Klijian","year":"2021","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2025.08.044_bib0032","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13054-020-2743-8","article-title":"Vasoplegic syndrome following cardiothoracic surgery\u2014Review of pathophysiology and update of treatment options","volume":"24","author":"Busse","year":"2020","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2025.08.044_bib0033","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1055\/s-2002-23491","article-title":"Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism","volume":"110","author":"Trenkel","year":"2002","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1053\/j.jvca.2025.08.044_bib0034","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/CCM.0000000000005143","article-title":"Renin kinetics are superior to lactate kinetics for predicting in-hospital mortality in hypotensive critically ill patients","volume":"50","author":"Jeyaraju","year":"2022","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2025.08.044_bib0035","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1515\/cclm-2022-1190","article-title":"Standard \u201320\u00b0C freezer storage protocols may cause substantial plasma renin cryoactivation","volume":"61","author":"Bonnitcha","year":"2023","journal-title":"Clin Chem Lab Med"},{"key":"10.1053\/j.jvca.2025.08.044_bib0036","first-page":"51","article-title":"New insights in ARDS pathogenesis","volume":"18","author":"Gonz\u00e1lez-Rodr\u00edguez","year":"2022","journal-title":"SignaVitae"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077025007207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077025007207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T13:13:41Z","timestamp":1774962821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053077025007207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1053077025007207"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2025.08.044","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world Experience of Angiotensin II and Renin Usage in Patients With Distributive Shock:A Single-center Descriptive Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2025.08.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}